Literature DB >> 26772061

Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution.

Paolo Fusar-Poli1, Frauke Schultze-Lutter2, Jean Addington3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26772061     DOI： 10.1016/S2215-0366(15)00491-5

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  15 in total

1.  Improving outcomes of first-episode psychosis: an overview.

Authors:  Paolo Fusar-Poli; Patrick D McGorry; John M Kane
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

2.  What causes psychosis? An umbrella review of risk and protective factors.

Authors:  Joaquim Radua; Valentina Ramella-Cravaro; John P A Ioannidis; Abraham Reichenberg; Nacharin Phiphopthatsanee; Taha Amir; Hyi Yenn Thoo; Dominic Oliver; Cathy Davies; Craig Morgan; Philip McGuire; Robin M Murray; Paolo Fusar-Poli
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

3.  The Clinical High-Risk State for Psychosis (CHR-P), Version II.

Authors:  Paolo Fusar-Poli
Journal:  Schizophr Bull       Date:  2017-01       Impact factor: 9.306

4.  Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis.

Authors:  Dominic Oliver; Maite Arribas; Joaquim Radua; Gonzalo Salazar de Pablo; Andrea De Micheli; Giulia Spada; Martina Maria Mensi; Magdalena Kotlicka-Antczak; Renato Borgatti; Marco Solmi; Jae Il Shin; Scott W Woods; Jean Addington; Philip McGuire; Paolo Fusar-Poli
Journal:  Mol Psychiatry       Date:  2022-06-03       Impact factor: 15.992

5.  Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis.

Authors:  Paolo Fusar-Poli; Andrea De Micheli; Marco Cappucciati; Grazia Rutigliano; Cathy Davies; Valentina Ramella-Cravaro; Dominic Oliver; Ilaria Bonoldi; Matteo Rocchetti; Lauren Gavaghan; Rashmi Patel; Philip McGuire
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 7.348

6.  Transdiagnostic Individualized Clinically Based Risk Calculator for the Detection of Individuals at Risk and the Prediction of Psychosis: Model Refinement Including Nonlinear Effects of Age.

Authors:  Paolo Fusar-Poli; Cathy Davies; Grazia Rutigliano; Daniel Stahl; Ilaria Bonoldi; Philip McGuire
Journal:  Front Psychiatry       Date:  2019-05-09       Impact factor: 4.157

7.  Real World Implementation of a Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk of Psychosis in Clinical Routine: Study Protocol.

Authors:  Paolo Fusar-Poli; Dominic Oliver; Giulia Spada; Rashmi Patel; Robert Stewart; Richard Dobson; Philip McGuire
Journal:  Front Psychiatry       Date:  2019-03-13       Impact factor: 4.157

8.  Pan-London Network for Psychosis-Prevention (PNP).

Authors:  Paolo Fusar-Poli; Andrés Estradé; Tom J Spencer; Susham Gupta; Silvia Murguia-Asensio; Savithasri Eranti; Kerry Wilding; Olivier Andlauer; Jonathan Buhagiar; Martin Smith; Sharon Fitzell; Victoria Sear; Adelaide Ademan; Andrea De Micheli; Philip McGuire
Journal:  Front Psychiatry       Date:  2019-10-11       Impact factor: 4.157

9.  Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS.

Authors:  P Fusar-Poli; M Cappucciati; G Rutigliano; T Y Lee; Q Beverly; I Bonoldi; J Lelli; S J Kaar; E Gago; M Rocchetti; R Patel; V Bhavsar; S Tognin; S Badger; M Calem; K Lim; J S Kwon; J Perez; P McGuire
Journal:  Psychiatry J       Date:  2016-05-30

10.  Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust.

Authors:  Paolo Fusar-Poli; Nomi Werbeloff; Grazia Rutigliano; Dominic Oliver; Cathy Davies; Daniel Stahl; Philip McGuire; David Osborn
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.